ResearcherUniversity of Pittsburgh Medical CenterActive in the last 2 years

Jurgis Alvikas

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1167-6546; OpenAlex author ID A5073300004. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2025: 1 paper

Papers 1

Survival prediction for CA19-9 non-producers with resected pancreatic cancer. Co-author DOI 10.1016/j.hpb.2025.05.007 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Genia Dubrovsky · 1 shared paper, 2025 · strength 0.24
- Paper Survival prediction for CA19-9 non-producers with resected pancreatic cancer. DOI 10.1016/j.hpb.2025.05.007 ↗
Asmita Chopra · 1 shared paper, 2025 · strength 0.24
- Paper Survival prediction for CA19-9 non-producers with resected pancreatic cancer. DOI 10.1016/j.hpb.2025.05.007 ↗
Amer H. Zureikat · 1 shared paper, 2025 · strength 0.24
- Paper Survival prediction for CA19-9 non-producers with resected pancreatic cancer. DOI 10.1016/j.hpb.2025.05.007 ↗
Jiage Qian · 1 shared paper, 2025 · strength 0.24
- Paper Survival prediction for CA19-9 non-producers with resected pancreatic cancer. DOI 10.1016/j.hpb.2025.05.007 ↗
Sebastiaan Ceuppens · 1 shared paper, 2025 · strength 0.24
- Paper Survival prediction for CA19-9 non-producers with resected pancreatic cancer. DOI 10.1016/j.hpb.2025.05.007 ↗
Alessandro Paniccia · 1 shared paper, 2025 · strength 0.24
- Paper Survival prediction for CA19-9 non-producers with resected pancreatic cancer. DOI 10.1016/j.hpb.2025.05.007 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.